LFG
NVO

Larson Financial Group’s Novo Nordisk NVO Stock Holding History

Larson Financial Group’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-100
Closed -$21 – 3606
2025
Q3 		$21 Hold
100
– – ﹤0.01% 3394
2025
Q2 		$69 Hold
100
– – ﹤0.01% 3204
2025
Q1 		$155 Sell
100
-100
-50% -$8.26K ﹤0.01% 2841
2024
Q4 		$357 Hold
200
– – ﹤0.01% 2290
2024
Q3 		$4.25K Buy
+200
New +$26.7K ﹤0.01% 1701

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Larson Financial Group's NVO Position: Q1 2026 in Review

Larson Financial Group increased its Novo Nordisk (NVO) stake by 125% in Q1 2026, buying an estimated $96.1K and bringing the position to 3,646 shares worth $134K. The position accounts for ﹤0.01% of the portfolio, ranked #869.

Larson Financial Group first reported a position in NVO in Q2 2022 and has held it in 16 quarters since. The position peaked at $362K in Q3 2024. 1,273 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • Larson Financial Group held 3,646 shares of Novo Nordisk worth $134K as of Q1 2026.
  • Larson Financial Group bought 2,028 Novo Nordisk shares in Q1 2026, an estimated $96.1K.
  • Novo Nordisk made up ﹤0.01% of Larson Financial Group's portfolio in Q1 2026, its #869 holding.
  • Larson Financial Group first reported a position in Novo Nordisk in Q2 2022 and has held it in 16 quarters since.
  • Larson Financial Group's Novo Nordisk position peaked at $362K in Q3 2024.
  • 1,273 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Larson Financial Group's 13F filing for Q1 2026, filed 15 May 2026.